Lathrop Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1M Buy
30,770
+393
+1% +$213K 2.83% 15
2025
Q4
$17.6M Sell
30,377
-130
-0.4% -$73.5K 3.19% 9
2025
Q3
$14.8M Buy
30,507
+1,005
+3% +$468K 2.73% 18
2025
Q2
$12M Buy
29,502
+834
+3% +$349K 2.26% 24
2025
Q1
$14.3M Sell
28,668
-1,109
-4% -$601K 2.83% 18
2024
Q4
$15.5M Sell
29,777
-970
-3% -$533K 2.95% 11
2024
Q3
$19M Sell
30,747
-437
-1% -$259K 3.53% 5
2024
Q2
$17.2M Sell
31,184
-455
-1% -$261K 3.37% 9
2024
Q1
$18.4M Sell
31,639
-616
-2% -$346K 3.56% 6
2023
Q4
$17.1M Sell
32,255
-381
-1% -$184K 3.49% 8
2023
Q3
$16.5M Sell
32,636
-115
-0.4% -$61.3K 3.56% 8
2023
Q2
$17.1M Sell
32,751
-5
-0% -$2.7K 3.47% 6
2023
Q1
$18.9M Sell
32,756
-206
-0.6% -$116K 4.01% 3
2022
Q4
$18.2M Buy
32,962
+181
+0.6% +$95.9K 4.01% 2
2022
Q3
$16.6M Sell
32,781
-506
-2% -$283K 4.39% 3
2022
Q2
$18.1M Sell
33,287
-42
-0.1% -$23.1K 4.52% 2
2022
Q1
$19.7M Sell
33,329
-2,110
-6% -$1.21M 4.16% 2
2021
Q4
$23.6M Sell
35,439
-572
-2% -$357K 4.65% 2
2021
Q3
$20.6M Sell
36,011
-1,539
-4% -$845K 4.4% 2
2021
Q2
$18.9M Sell
37,550
-2,500
-6% -$1.18M 3.91% 5
2021
Q1
$18.3M Sell
40,050
-1,057
-3% -$505K 4.09% 4
2020
Q4
$19.1M Sell
41,107
-6,252
-13% -$2.93M 4.73% 2
2020
Q3
$20.9M Sell
47,359
-1,611
-3% -$666K 5.91% 2
2020
Q2
$17.7M Sell
48,970
-3,764
-7% -$1.26M 5.3% 3
2020
Q1
$15M Sell
52,734
-9,911
-16% -$3.13M 5.27% 3
2019
Q4
$20.4M Sell
62,645
-2,458
-4% -$745K 5.42% 2
2019
Q3
$19M Buy
65,103
+228
+0.4% +$65.3K 5.24% 2
2019
Q2
$19.1M Sell
64,875
-2,020
-3% -$556K 5.41% 2
2019
Q1
$18.3M Sell
66,895
-3,702
-5% -$921K 5.45% 2
2018
Q4
$15.8M Sell
70,597
-8,848
-11% -$2.08M 5.53% 3
2018
Q3
$19.4M Sell
79,445
-1,833
-2% -$422K 5.01% 3
2018
Q2
$16.8M Sell
81,278
-1,611
-2% -$342K 4.57% 4
2018
Q1
$17.1M Sell
82,889
-4,033
-5% -$847K 4.9% 4
2017
Q4
$16.5M Sell
86,922
-2,540
-3% -$487K 4.54% 6
2017
Q3
$16.9M Sell
89,462
-1,695
-2% -$307K 4.74% 3
2017
Q2
$15.9M Sell
91,157
-1,790
-2% -$301K 4.54% 3
2017
Q1
$14.3M Sell
92,947
-1,561
-2% -$239K 4.16% 5
2016
Q4
$13.3M Sell
94,508
-91,478
-49% -$13.5M 4.02% 10
2016
Q3
$28.5M Buy
185,986
+92,660
+99% +$14.3M 4.37% 3
2016
Q2
$13.8M Buy
93,326
+410
+0.4% +$60.5K 4.28% 4
2016
Q1
$13.2M Buy
92,916
+440
+0.5% +$59K 4.17% 7
2015
Q4
$13.1M Sell
92,476
-1,460
-2% -$195K 4.29% 8
2015
Q3
$11.5M Buy
93,936
+5,655
+6% +$737K 3.93% 9
2015
Q2
$11.5M Buy
88,281
+1,801
+2% +$235K 3.76% 10
2015
Q1
$11.6M Buy
86,480
+1,150
+1% +$148K 4.01% 7
2014
Q4
$10.7M Buy
85,330
+610
+0.7% +$74.2K 3.86% 5
2014
Q3
$10.3M Sell
84,720
-1,789
-2% -$218K 3.92% 6
2014
Q2
$10.2M Sell
86,509
-946
-1% -$111K 3.88% 7
2014
Q1
$10.5M Buy
87,455
+347
+0.4% +$41.3K 4.2% 4
2013
Q4
$9.7M Buy
87,108
+470
+0.5% +$46.7K 4.12% 4
2013
Q3
$7.98M Buy
86,638
+1,869
+2% +$169K 3.74% 7
2013
Q2
$7.17M Buy
+84,769
New +$7.06M 3.63% 9

Other funds holding TMO

Lathrop Investment Management's TMO Position: Q1 2026 in Review

Lathrop Investment Management increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2026, buying an estimated $213K and bringing the position to 30,770 shares worth $15.1M. The position accounts for 2.83% of the portfolio, ranked #15.

Lathrop Investment Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.5M in Q3 2016. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Lathrop Investment Management held 30,770 shares of Thermo Fisher Scientific worth $15.1M as of Q1 2026.
  • Lathrop Investment Management bought 393 Thermo Fisher Scientific shares in Q1 2026, an estimated $213K.
  • Thermo Fisher Scientific made up 2.83% of Lathrop Investment Management's portfolio in Q1 2026, its #15 holding.
  • Lathrop Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Lathrop Investment Management's Thermo Fisher Scientific position peaked at $28.5M in Q3 2016.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lathrop Investment Management's 13F filing for Q1 2026, filed 12 May 2026.